Duey Marc's Form 4 filing
Aprea Therapeutics, Inc. (APRE) · filed Oct 25, 2024
- Accession no.
- 0001104659-24-111548
- Filed
- Oct 25, 2024
- Trade date
- Oct 18, 2024
- Filing delay
- 7 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $29.6K. It was filed 7 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Duey MarcCIK 0001925150 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 18, 2024 | Common Stock | SSaleDisposed | −6,462 | $4.58F2 | −$29,595.96 | 233,651 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
These shares were sold in multiple transactions on October 18, 2024, each at $4.578 per share.
Referenced by the price of 1 transaction in Table I.